HuGE Literature Finder
Records 1-30
|
Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation.
Scientific reports 2019 Mar 9 (1): 3750. Ibrahim-Kosta M, Suchon P, Couturaud F, Smadja D, Olaso R, Germain M, Saut N, Goumidi L, Derbois C, Thibord F, Debette S, Amouyel P, Deleuze J F, van Doorn P, Castoldi E, Patin E, Alessi M C, Trégouët D A, Morange P |
|
Association between in vitro fertilization outcomes and inherited thrombophilias: a meta-analysis.
Journal of assisted reproduction and genetics 2016 May . Tan Xiaofang, Yu Zhenbo, Sao Jun, Chen Li, Shen Ya, Ding Jiayi, Shi Weiho |
|
Factors contributing to APC-resistance in women with recurrent spontaneous miscarriages: Indian perspective.
Blood cells, molecules & diseases 2015 Oct 55 (3): 213-5. Sharma Amit, Singh Neha, Mahapatra Manoranjan, Ranjan Ravi, Kishor Kamal, Saxena Re |
|
Prevalence of the Factor V E666D Mutation and Its Correlation With Activated Protein C Resistance in the Chinese Population.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015 Jul 21 (5): 480-3. Xin-Guang Chen, Yong-Qiang Zhao, Shu-Jie Wang, Lian-Kai Fan, Hua-Cong C |
|
Ethnic differences in the association of thrombophilic polymorphisms with obstetric complications in Slovak and Roma (Gypsy) populations.
Genetic testing and molecular biomarkers 2015 Feb 19 (2): 98-102. Bozikova Alexandra, Gabrikova Dana, Pitonak Jozef, Bernasovska Jarmila, Macekova Sona, Lohajova-Behulova Regi |
|
Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
Journal of thrombosis and haemostasis : JTH 2015 Jan 13 (1): 17-22. Pabinger I, Ay C, Dunkler D, Thaler J, Reitter E-M, Marosi C, Zielinski C, Mannhalter |
|
Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis.
Blood transfusion = Trasfusione del sangue 2014 Jan 12 Suppl 1 s337-42. Tufano Antonella, Guida Anna, Coppola Antonio, Nardo Assunta, Di Capua Mirko, Quintavalle Gabriele, Di Minno Matteo Nicola Dario, Cerbone Anna Maria, Di Minno Giovan |
|
An improved algorithm for activated protein C resistance and factor V Leiden screening.
American journal of clinical pathology 2013 Sep 140 (3): 379-86. Herskovits Adrianna Z, Morgan Elizabeth A, Lemire Susan J, Lindeman Neal I, Dorfman David |
|
A gene-centric analysis of activated partial thromboplastin time and activated protein C resistance using the HumanCVD focused genotyping array.
European journal of human genetics : EJHG 2013 Jul 21 (7): 779-83. Gaunt Tom R, Lowe Gordon D O, Lawlor Debbie A, Casas Juan-Pablo, Day Ian N |
|
Factor V leiden and ischemic stroke risk: the Genetics of Early Onset Stroke (GEOS) study.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2013 May 22 (4): 419-23. Hamedani Ali G, Cole John W, Cheng Yuching, Sparks Mary J, O'Connell Jeffrey R, Stine Oscar C, Wozniak Marcella A, Stern Barney J, Mitchell Braxton D, Kittner Steven |
|
APC resistance due to Factor V Leiden is not related to baseline inflammatory mediators or survival up to 10 years in patients with critical limb ischemia.
Journal of thrombosis and thrombolysis 2012 Dec . Sampram ES, Gottsäter A, Lindblad B, Svensson PJ |
|
The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia.
Journal of thrombosis and thrombolysis 2012 Oct 34 (3): 406-9. Bôžiková Alexandra, Gabriková Dana, Sovi?ová Adriana, Behulová Regina, Ma?eková So?a, Boro?ová Iveta, Petrej?íková Eva, Soták Miroslav, Bernasovská Jarmila, Bernasovský Iv |
|
Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.
Molecular biology reports 2012 Sep 39 (9): 9133-8. Dajani Rana, Fatahallah Raja, Dajani Abdelrahman, Al-Shboul Mohammad, Khader Yous |
|
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes.
Journal of thrombosis and haemostasis : JTH 2012 Jan 10 (1): 73-80. Segers O, Simioni P, Tormene D, Bulato C, Gavasso S, Rosing J, Castoldi Elisabet |
|
Thrombophilia among Chinese women with venous thromboembolism during pregnancy.
Gynecologic and obstetric investigation 2012 73 (3): 183-8. Tam Wing-Hung, Ng Margaret Heung-Ling, Yiu Alice Ka-Wah, Lau Kin-Mang, Cheng Gregory Yin-Ming, Li Chi-Y |
|
Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
British journal of haematology 2011 Jul 154 (2): 241-7. Bergrem Astrid, Dahm Anders Erik Astrup, Jacobsen Anne Flem, Mowinckel Marie-Christine, Sandvik Leiv, Sandset Per Mort |
|
Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: a controlled study.
Thrombosis research 2011 Feb 127 (2): 85-90. Dragoni Francesco, Chiarotti Flavia, Rosano Giuseppe, Simioni Paolo, Tormene Daniela, Mazzucconi Maria Gabriella, Cafolla Arturo, Avvisati Giusep |
|
Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women.
Journal of pregnancy 2011 2011 232840. Sedano-Balbás Sara, Lyons Mark, Cleary Brendan, Murray Margaret, Gaffney Geraldine, Maher Majel |
|
Frequency of prothrombotic risk factors in patients with deep venous thrombosis and controls: their implications for thrombophilia screening in Chilean subjects.
Genetic testing and molecular biomarkers 2010 Oct 14 (5): 599-602. Guzmán Neftalí, Salazar Luis |
|
The effect of homocysteine on the clinical outcomes of ventilated patients with severe sepsis.
Minerva anestesiologica 2010 Oct 76 (10): 787-94. Tsantes A, Tsangaris I, Nikolopoulos G, Bagos P, Kopterides P, Antonakos G, Dimopoulou I, Vrioni G, Kapsimali V, Dima K, Armaganidis A, Travlou |
|
Circulating microparticles are elevated in carriers of factor V Leiden.
Thrombosis research 2010 Sep 126 (3): 250-3. Enjeti Anoop K, Lincz Lisa F, Scorgie Fiona E, Seldon Micha |
|
High prevalence of activated protein C resistance and factor V Leiden mutation in an Arab population and patients with venous thrombosis in Kuwait.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2010 Sep 19 (3): 180-3. Jadaon Mehrez M, Dashti Ali A, Lewis Hend |
|
Usefulness of factor V Leiden mutation testing in clinical practice.
European journal of human genetics : EJHG 2010 Aug 18 (8): 862-6. Blinkenberg Ellen Ø, Kristoffersen Ann-Helen, Sandberg Sverre, Steen Vidar M, Houge Gunn |
|
The effect of homocysteine on the clinical outcomes of ventilated patients with severe sepsis.
Minerva anestesiologica 2010 Jul . Tsantes A, Tsangaris I, Nikolopoulos G, Bagos P, Kopterides P, Antonakos G, Dimopoulou I, Vrioni G, Kapsimali V, Dima K, Armaganidis A, Travlou A |
|
Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype.
International journal of hematology 2010 Apr 91 (3): 549-50. Okada Hiromi, Toyoda Yoshimi, Takagi Akira, Saito Hidehiko, Kojima Tetsuhito, Yamazaki Tom |
|
Increased sperm count may account for high population frequency of factor V Leiden.
Journal of thrombosis and haemostasis : JTH 2010 Mar 8 (3): 513-6. Cohn D M, Repping S, Büller H R, Meijers J C M, Middeldorp |
|
Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010 Jan 21 (1): 11-5. DeSancho Maria Teresa, Berlus Nickisha, Christos Paul J, Rand Jac |
|
APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women.
BMC pregnancy and childbirth 2010 10 (1): 11. Sedano-Balbás Sara, Lyons Mark, Cleary Brendan, Murray Margaret, Gaffney Geraldine, Maher Majel |
|
Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Thrombosis research 2009 Jun 124 (2): 178-84. Chaireti Roza, Jennersjö Cecilia, Lindahl Tomas |
|
Activated protein C resistance and factor V Leiden in Mexico.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2008 Oct 14 (4): 428-37. Majluf-Cruz Abraham, Moreno-Hernández Manuel, Ruiz-de-Chávez-Ochoa Adriana, Monroy-García Rosario, Majluf-Cruz Karim, Guardado-Mendoza Rodolfo, Molina-Avila Irma, Isordia-Salas Irma, Corona-de la Peña Norma, Vargas-Vorackova Florencia, Vela-Ojeda Jorge, García-Chávez Jai |
|
Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndrome.
Critical care medicine 2008 Jun 36 (6): 1776-9. Adamzik Michael, Frey Ulrich H, Riemann Kathrin, Sixt Stephan, Lehmann Nils, Siffert Winfried, Peters Jürg |
|
Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?
Clinica chimica acta; international journal of clinical chemistry 2008 Jun 392 (1-2): 21-4. Biswas Arijit, Bajaj Jyoti, Ranjan Ravi, Meena Arvind, Akhter Mohd Suhail, Yadav Birendra Kumar, Sharma Vinita, Saxena Re |
|
Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head.
Clinical orthopaedics and related research 2008 May 466 (5): 1034-40. Glueck Charles J, Freiberg Richard A, Wang Pi |
|
The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
Thrombosis and haemostasis 2008 May 99 (5): 925-9. Rehak Matus, Rehak Jiri, Müller Marc, Faude Susanne, Faude Frank, Siegemund Annelie, Krcova Vera, Slavik Ludek, Hasenclever Dirk, Scholz Markus, Wiedemann Pet |
|
Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study.
Journal of thrombosis and haemostasis : JTH 2008 Apr 6 (4): 632-7. Pomp E R, Lenselink A M, Rosendaal F R, Doggen C J |
|
The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion.
Human reproduction (Oxford, England) 2008 Feb 23 (2): 278-84. Bellver José, Soares Sergio R, Alvarez Claudio, Muñoz Elkin, Ramírez Alberto, Rubio Carmen, Serra Vicente, Remohí José, Pellicer Anton |
|
Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis.
Neurology 2008 Feb 70 (8): 627-33. Wysokinska E M, Wysokinski W E, Brown R D, Karnicki K, Gosk-Beirska I, Grill D, McBane R |
|
Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women.
Acta obstetricia et gynecologica Scandinavica 2008 87 (6): 635-42. Muetze Sabine, Leeners Brigitte, Ortlepp Jan R, Kuse Sabine, Tag Carmen G, Weiskirchen Ralf, Gressner Axel M, Rudnik-Schoeneborn Sabine, Zerres Klaus, Rath Wern |
|
A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
Experimental and molecular pathology 2007 Dec 83 (3): 480-3. Bouaziz-Borgi Lobna, Nguyen Philipe, Hezard Nathalie, Musharrafieh Umayya, Almawi Wassim Y, Mahjoub Touha |
|
Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007 Oct 18 (7): 603-10. Gessoni Gianluca, Valverde Sa |
|
Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR.
Human reproduction (Oxford, England) 2007 Sep 22 (9): 2546-53. Dawood Feroza, Mountford Roger, Farquharson Roy, Quenby Siobh |
|
Frequency of selected thrombophilias in women with placental abruption.
The Australian & New Zealand journal of obstetrics & gynaecology 2007 Aug 47 (4): 297-301. Procházka Martin, Lubuský Marek, Slavík Ludek, Hrachovec Petr, Zielina Petr, Kudela Milan, Lindqvist Pelle |
|
The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
Haematologica 2007 Aug 92 (8): 1107-14. Marchiori Antonio, Mosena Laura, Prins Martin H, Prandoni Pao |
|
[Analysis of activated protein C resistance, factor V coagulation activity and gene polymorphisms in patients with venous thromboembolism].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2007 Jun 15 (3): 612-6. Han Xuan-Mao, Ren Jin-Fang, Hao Bin, Cao Wen-Dong, Liu Xiu-E, Hou Li-Hong, Guo Zhi-Ping, Yu Bin, Wang Xue-Feng, Ding Qiu-Lan, Yang Lin-H |
|
Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
American journal of hematology 2006 Dec 81 (12): 933-7. Torres J D, Cardona H, Alvarez L, Cardona-Maya W, Castañeda S A, Quintero-Rivera F, Cadavid A, Bedoya G, Tobón |
|
Genetic polymorphisms of hemostasis genes and primary outcome of very low birth weight infants.
Pediatrics 2006 Aug 118 (2): 683-9. Härtel Christoph, König Inke, Köster Stefan, Kattner Evelyn, Kuhls Eckhardt, Küster Helmut, Möller Jens, Müller Dirk, Kribs Angela, Segerer Hugo, Wieg Christian, Herting Egbert, Göpel Wolfga |
|
The Leiden mutation and activated protein C resistance as risk factors for disseminated intravascular coagulation in acutely poisoned patients.
Clinical toxicology (Philadelphia, Pa.) 2006 44 (1): 53-7. Prazanowski Miros?aw, Kur Barbara, Bara?ska Ma?gorzata, Lutz Waldemar, Pi?acik Bozena, Kolaci?ski Zbigni |
|
Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.
European journal of gastroenterology & hepatology 2005 Jul 17 (7): 739-44. Mahmood Asif, Needham Jane, Prosser Jeanne, Mainwaring Jason, Trebble Tim, Mahy Gillian, Ramage Jo |
|
Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation.
Transplantation 2005 May 79 (10): 1422-7. Loew Andreas, Jacob Dietmar, Neuhaus Peter, Riess Han |
|
Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss.
European journal of obstetrics, gynecology, and reproductive biology 2005 Apr 119 (2): 164-70. Mtiraoui Nabil, Borgi Lobna, Hizem Sondes, Nsiri Brahim, Finan Ramzi R, Gris Jean-Christophe, Almawi Wassim Y, Mahjoub Touha |
|
The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels.
Thrombosis and haemostasis 2005 Mar 93 (3): 453-6. Scanavini Daniela, Legnani Cristina, Lunghi Barbara, Mingozzi Federico, Palareti Gualtiero, Bernardi Frances |
|
Factor V leiden is a risk factor for myocardial infarction in young Turkish men.
Acta cardiologica 2004 Dec 59 (6): 594-7. Hobikoglu Gultekin F, Akyuz Umit, Akyuz Filiz, Ozer Orhan, Güney Dilvin, Narin Ahmet, Unaltuna Nih |
|
Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
Annals of hematology 2004 Nov 83 (11): 712-5. El-Karaksy Hanaa, El-Koofy Nehal, El-Hawary Manal, Mostafa Azza, Aziz Mona, El-Shabrawi Mortada, Mohsen Nabil A, Kotb Magd, El-Raziky Mona, El-Sonoon Marwa Abu, A-Kader Hass |
|
The predictability of factor V Leiden (FV:Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004 Jul 10 (3): 265-70. Sayinalp N, Haznedaro?lu I C, Aksu S, Büyüka?ik Y, Göker H, Parlak H, Ozcebe O I, Kirazli S, Dündar S V, Gürgey |
|
Hyperhomocysteinemia and other thrombophilic risk factors in 26 patients with cerebral venous thrombosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2004 Jun 11 (6): 405-9. Boncoraglio G, Carriero M R, Chiapparini L, Ciceri E, Ciusani E, Erbetta A, Parati E |
|
Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
American heart journal 2004 May 147 (5): 897-904. Middendorf Katharina, Göhring Peter, Huehns Tanya Y, Seidel Dietrich, Steinbeck Gerhard, Nikol Sigr |
|
Oral contraceptive use in women with poor anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis.
Thrombosis and haemostasis 2004 Apr 91 (4): 712-8. Legnani Cristina, Cini Michela, Cosmi Benilde, Mattarozzi Silvia, Lo Manto Giuseppa, Palareti Gualtie |
|
MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
La Clinica terapeutica 2004 154 (5): 299-303. Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C |
|
The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.
Haematologica 2004 Feb 89 (2): 201-6. Van Rooden CJ, Rosendaal FR, Meinders AE, Van Oostayen JA, Van Der Meer FJ, Huisman MV |
|
Modulation of factor V levels in plasma by polymorphisms in the C2 domain.
Arteriosclerosis, thrombosis, and vascular biology 2004 Jan 24 (1): 200-6. Scanavini Daniela, Girelli Domenico, Lunghi Barbara, Martinelli Nicola, Legnani Cristina, Pinotti Mirko, Palareti Gualtiero, Bernardi Frances |
|
[Factor V Leiden and the Slovak population].
Vnitr?ní lékar?ství 2003 Nov 49 (11): 845-50. Hudecek J, Dobrotová M, Hybenová J, Ivanková J, Melus V, Pullmann R, Kubisz |
|
Evaluation of the Roche LightCycler: a simple and rapid method for direct detection of factor V Leiden and prothrombin G20210A genotypes from blood samples without the need for DNA extraction.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003 Jul 14 (5): 499-503. Cooper Peter C, Cooper Susan M, Smith Julie M, Kitchen Steven, Makris Micha |
|
A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers.
Thrombosis and haemostasis 2003 Jun 89 (6): 983-9. Mingozzi Federico, Legnani Cristina, Lunghi Barbara, Scanavini Daniela, Castoldi Elisabetta, Palareti Gualtiero, Marchetti Giovanna, Bernardi Frances |
|
[Occurrence of gene mutations in factor V Leiden, prothrombin and methylenetetrahydrofolate reductase in patients with pre-eclampsia].
Ceská gynekologie / Ceská lékarská spolecnost J. Ev. Purkyne 2003 May 68 (3): 162-6. Procházka M, Krcová V, Kudela M, Slavík |
|
Factor V Leiden in pregnancies complicated by placental abruption.
BJOG : an international journal of obstetrics and gynaecology 2003 May 110 (5): 462-6. Procházka Martin, Happach Catharina, Marsál Karel, Dahlbäck Björn, Lindqvist Pelle |
|
Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.
Blood 2003 Apr 101 (8): 3037-41. Butt Christopher, Zheng Hong, Randell Edward, Robb Desmond, Parfrey Patrick, Xie Ya-Ga |
|
Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.
The British journal of ophthalmology 2003 Mar 87 (3): 305-6. Hvarfner C, Hillarp A, Larsson |
|
No association between thrombosis and factor V gene polymorphisms in Chinese Han population.
Thrombosis and haemostasis 2003 Mar 89 (3): 446-51. Yanqing Hu, Fangping Chen, Qinzhi Xie, Zaifu Jian, Guangping Wang, Xiaoxia Zuo, Xiaoqun Pu, Xiaob |
|
The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation.
Haematologica 2003 Mar 88 (3): 286-9. Bossone Anna, Cappucci Filomena, D'Andrea Giovanna, Brancaccio Vincenzo, Cibelli Giuseppe, Iannaccone Luigi, Grandone Elvira, Margaglione Mauriz |
|
Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003 Jan 14 (1): 49-56. Kostka Heike, Schwarz Thomas, Schellong Sebastian, Mix Cornelia, Kuhlisch Eberhard, Temelkova-Kurktschiev Theodora, Henkel Elena, Köhler Carsta, Gehrisch Siegmund, Siegert Gabrie |
|
[Activated protein C resistance and deep venous thrombosis in pregnancy].
Ceská gynekologie / Ceská lékarská spolecnost J. Ev. Purkyne 2002 Sep 67 (5): 251-4. Procházka M, Krcová V, Hrachovec P, Kudela M, Slavík |
|
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
American journal of hematology 2002 Sep 71 (1): 1-6. Ruggeri Marco, Gisslinger Heinz, Tosetto Alberto, Rintelen Claudia, Mannhalter Christine, Pabinger Ingrid, Heis Navide, Castaman Giancarlo, Missiaglia Edoardo, Lechner Klaus, Rodeghiero Frances |
|
Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002 Jul 13 (5): 373-81. Kemmeren J M, Algra A, Meijers J C M, Bouma B N, Grobbee D |
|
Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Thrombosis and haemostasis 2002 Jul 88 (1): 5-11. Curvers Joyce, Thomassen M Christella L G D, Rimmer Janet, Hamulyak Karly, van der Meer Jan, Tans Guido, Preston F Eric, Rosing J |
|
Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Thrombosis and haemostasis 2002 May 87 (5): 791-5. Martinelli Ida, De Stefano Valerio, Taioli Emanuela, Paciaroni Katia, Rossi Elena, Mannucci Pier Mannucc |
|
Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review.
Thrombosis and haemostasis 2002 May 87 (5): 779-85. Morrison E R, Miedzybrodzka Z H, Campbell D M, Haites N E, Wilson B J, Watson M S, Greaves M, Vickers M |
|
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002 Apr 13 (3): 187-92. Zangari M, Saghafifar F, Anaissie E, Badros A, Desikan R, Fassas A, Mehta P, Morris C, Toor A, Whitfield D, Siegel E, Barlogie B, Fink L, Tricot |
|
Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Thrombosis and haemostasis 2002 Apr 87 (4): 580-5. Wåhlander K, Larson G, Lindahl T L, Andersson C, Frison L, Gustafsson D, Bylock A, Eriksson B |
|
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
Thrombosis research 2002 Apr 106 (1): 59-62. Antovic Jovan P, Blombäck Margare |
|
[ABO/H blood groups and factor V Leiden].
Casopís lékar?? c?eských 2002 Mar 141 (5): 146-51. Matýsková M, Zavrelová J, Pejchalová A, Meluzinová H, Jank? |
|
Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients.
Thrombosis and haemostasis 2002 Feb 87 (2): 194-8. Hocher Berthold, Slowinski Torsten, Hauser Ingeborg, Vetter Birgit, Fritsche Lutz, Bachert Daniela, Kulozik Andreas, Neumayer Hans |
|
Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Thrombosis and haemostasis 2002 Feb 87 (2): 199-205. Kemmeren J M, Algra A, Meijers J C M, Bouma B N, Grobbee D |
|
Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations.
Haematologica 2002 Feb 87 (2): 177-81. Grandone Elvira, Margaglione Maurizio, Colaizzo Donatella, Pavone Giuseppe, Paladini Dario, Martinelli Pasquale, Di Minno Giovan |
|
Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity.
Blood 2002 Jan 99 (2): 437-42. Raife Thomas J, Lentz Steven R, Atkinson Bonnie S, Vesely Sara K, Hessner Martin |
|
FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile.
Thrombosis and haemostasis 2002 Jan 87 (1): 32-6. Margaglione Maurizio, Bossone Anna, Coalizzo Donatella, D'Andrea Giovanna, Brancaccio Vincenzo, Ciampa Antonio, Grandone Elvira, Di Minno Giovan |
|
[Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2001 Dec 1 (4): 242-5; AXIV. Baykan M, Celik S, Uçar F, Kaplan S, Ovali E, Erdöl |
|
Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001 Oct 12 (7): 569-76. Quincampoix J C, Legarff M, Rittling C, Andiva S, Toulon |
|
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Thrombosis and haemostasis 2001 Sep 86 (3): 809-16. Emmerich J, Rosendaal F R, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny J |
|
The impact of factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2001 Aug 22 (2): 134-8. Sampram ES, Lindblad B |
|
Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage.
Human reproduction (Oxford, England) 2001 May 16 (5): 961-5. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, Regan |
|
Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
Journal of thrombosis and thrombolysis 2001 Apr 11 (2): 111-6. Irani-Hakime N, Tamim H, Elias G, Choueiry S, Kreidy R, Daccache J L, Almawi W |
|
Measurement of activated protein C resistance during menstrual cycle in women with and without the Leiden mutation.
Thrombosis and haemostasis 2001 Apr 85 (4): 614-8. Wramsby M L, Bremme K, Blombäck |
|
Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypes.
American journal of clinical pathology 2001 Mar 115 (3): 439-47. Parks S B, Popovich B W, Press R |
|
Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers.
The British journal of dermatology 2001 Mar 144 (3): 546-8. Gaber Y, Siemens H J, Schmeller |
|
Factor V Arg306 --> Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese.
Thrombosis and haemostasis 2001 Feb 85 (2): 270-3. Shen M C, Lin J S, Tsay |
|
Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
American journal of hematology 2001 Jan 66 (1): 28-31. Ruiz-Argüelles G J, Garcés-Eisele J, Reyes-Núñez V, Ramírez-Cisneros F |
|
Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion.
Retina (Philadelphia, Pa.) 2001 21 (2): 161-6. Johnson T M, El-Defrawy S, Hodge W G, Leonard B C, Kertes P J, Taylor SAM , Lillicrap D |
|
Factor V leiden and morbid obesity in fatal postoperative pulmonary embolism.
Archives of surgery (Chicago, Ill. : 1960) 2000 Dec 135 (12): 1410-3. Blaszyk H, Björnsson |
|
Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.
Thrombosis and haemostasis 2000 Oct 84 (4): 723-4. Mikovic D, Rakicevic L, Kovac M, Radojkovic |
|
Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas.
Journal of neurology 2000 Jul 247 (7): 521-3. Kraus J A, Stüper B K, Nahser H C, Klockgether T, Berlit |
- Page last reviewed:Mar 16, 2019
- Page last updated:Jun 03, 2020
- Content source: